Catheter repair for leaky mitral valve in heart failure
Part of Heart & circulation clinical trials.
This trial tests a new device (CathHELIX) placed through a vein to repair a leaky mitral valve in people with heart failure. It is for people with moderate to severe mitral regurgitation who still have symptoms despite medical therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe or severe functional mitral regurgitation (a leaky heart valve)
- Your heart's pumping strength is 30% or higher
- You have symptoms like shortness of breath or fatigue (NYHA class II to IV)
- You do not need oxygen at home for lung disease
- You have not had a heart transplant
- Your mitral valve and coronary vein anatomy are suitable for the device
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a catheter-based procedure can safely repair a leaking mitral heart valve in people who still have symptoms despite best medical treatment. If you qualify, it may improve symptoms and heart function without open-heart surgery.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial studies a new way to replace a damaged mitral heart valve using a catheter (a thin tube), instead of open-heart surgery. It may help people who have severe leaking of the mitral valve but are considered too high-risk for surgery.
This study tests a new catheter-based system to treat severe mitral valve leaking when open-heart surgery is considered high risk. It may help improve blood flow and symptoms by repairing the valve without open surgery, using ultrasound guidance and follow-up visits to track safety and results.
This trial tests a new device for people whose mitral valve leaks badly (grade 3+ or 4+) and who are not candidates for surgery. The device aims to fix the leak through a less invasive approach, and the study checks if it's safe and works well in daily life.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
Hear when a new Mitral Valve Regurgitation (Degenerative or Functional) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.